Camrelizumab Antibody
Camrelizumab (SHR-1210) is a high-affinity human IgG4-κ anti-PD-1 monoclonal antibody with a 3 nM binding affinity and 0.70 nM IC50 for PD-1/PD-L1 blockade. It demonstrates anti-tumor efficacy and tolerability in research models of cancers like NSCLC, ESCC, and HCC, supporting its investigation in immuno-oncology research.
Product Specifications
Product Name Alternative
PD1, PD-1, PD1/PDL1, PD-1/PD-L1, anti-PD-1, Camrelizumab, Camrelizumab (anti-PD-1), PDL1, PD-L1, SHR-1210, SHR 1210, SHR1210
Target
PD-1/PD-L1
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cell Biology, Immunology & Inflammation
Concentration
42.9 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
143.69 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Human Primary Antibody (IgG2) detection and titration ELISA kit, Qualitative (sufficient for 500-1000 tests)